T cell activation beads · Catalogue AH2001
Activation beads, functional antibodies and differentiation cocktails for T, Th1, Th2 and Treg work. ActBeads™ provide CD3/CD28 co-stimulation; EasyTune™ kits drive naive CD4⁺ T cells into polarised subsets within five days.
| Catalogue | Size | List price | Promo price | Manual | COA |
|---|---|---|---|---|---|
| AH2001L | 2 mL, 8x10^7 cells | ¥6333 | ¥3600 | Search | |
| AH2001M | 1 mL, 4x10^7 cells | ¥3333 | ¥2000 | Search | |
| AH2001S | 200 μL, 8x10^6 cells | ¥900 | ¥540 | Search |
Three-dimensional beads covalently coupled with CD3 and CD28 antibodies, mimicking antigen-presenting cells to deliver signal 1 and signal 2 for efficient expansion with reduced exhaustion.
| Parameter | Value |
|---|---|
| Bead concentration | 4 × 10⁷ beads/mL |
| Coupled antibodies | anti-human CD3 / anti-human CD28 |
| Buffer | PBS, 0.1% BSA |
| Size uniformity | Uniform; beads are clearly separable from T cells by flow cytometry |
| Storage | 4 °C, do not freeze |
| Shipping | 4 °C |
| Manual | v26.02 |
Medium: Eynos human T-cell medium (#C300100); FACS buffer (#EISO0500) for isolation. Cytokine: human IL-2 at 100 U/mL. IL-7 and IL-15 can be combined with IL-2 to support expansion.
ActBeads™ are used at a 1:1 bead-to-cell ratio for activation and expansion. For a 96-well plate, seed 0.8–1 × 10⁵ cells per well and add 2–2.5 μL of resuspended beads.
| Plate | Area | T cells | Beads | Medium |
|---|---|---|---|---|
| 96-well | 0.33 cm² | 1 × 10⁵ | 2.5 μL | 0.2 mL |
| 48-well | 1 cm² | 3 × 10⁵ | 7.5 μL | 0.5 mL |
| 24-well | 2 cm² | 6 × 10⁵ | 15 μL | 1 mL |
| 12-well | 4 cm² | 1.2 × 10⁶ | 30 μL | 2 mL |
| 6-well | 9 cm² | 2.4 × 10⁶ | 60 μL | 4 mL |
Keep FACS buffer osmolarity stable during isolation — immune cells are osmotically sensitive.
Activation and restimulation. Seed isolated T cells at 1 × 10⁵ per well (200 μL), add 2.5 μL of beads per well and IL-2 to 100 U/mL; culture at 37 °C, 5% CO₂. Cells enlarge and become morphologically diverse after 48 h. Between day 7 and 10, restimulate with fresh ActBeads™ and IL-2: place the suspension on a magnet for 2 minutes, decant the cells, count, and replate at 0.5–1 × 10⁶ cells/mL. CD8⁺ T cells retain cytotoxicity after repeated restimulation.
Bubbles usually come from protein-containing buffer. Fill the column with 3 mL of FACS buffer before pushing the cells out, and press the plunger once — do not pump repeatedly. If bubbles persist, switch to a high-quality PBS for the elution step.
No. Separation columns are single-use. Reuse reduces recovery and purity and carries a cross-contamination risk.
Retention is low when the labelling density and column load follow the manual. If purity is the priority for a low-abundance population, repeat the separation with a fresh column rather than washing the first one repeatedly.
CD45 marks all nucleated hematopoietic cells (leukocytes) — lymphocytes, monocytes, macrophages, granulocytes and dendritic cells. Mature red blood cells and platelets are CD45-negative. CD45 is therefore a pan-leukocyte marker, not a synonym for every immune cell type.
They are validated on PBMC, spleen, lymph node and bone marrow. Solid-tissue samples need proper dissociation and red-cell lysis first; recovery will depend on how well the single-cell suspension is prepared.
Each kit states a cell-number capacity (for example 1×10⁹ cells) rather than a sample count, because sample size varies. Divide your total cell number by that capacity to estimate how many experiments one kit supports.
Cell frequencies differ between strains and with age, which changes the starting purity but not the workflow. Record strain, age and sex so results stay comparable across experiments.
In human PBMC, T cells are roughly 45–70%, B cells 5–15%, NK cells 5–20% and monocytes 10–30%. In mouse spleen, B cells are around 45–55% and T cells around 30–40%. Treat these as typical ranges, not constants.
FACS buffer (PBS with 0.02% EDTA and 2% FBS) supplies protein to block non-specific binding and EDTA to prevent cell clumping. Using plain PBS lowers recovery and viability.
Nanobeads (about 50 nm) bind the target antigen and are retained in a magnetic field. They occupy only about 20–30% of the antigen epitopes, do not interfere with flow-cytometry staining and require no specific antibody clone. Because they are biodegradable and do not activate the cells, no removal step is required for most downstream assays.
Mouse spleen: B cells about 45–55%, T cells about 30–40%, and much smaller NK, DC and macrophage populations. Mouse bone marrow: CD117⁺ progenitors about 10–30%. Frequencies shift with strain and immune status.
Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.